Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-615-0063
Fax+1 215-349-8144
Dr. Hossain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nasheed Hossain is a hematologist based in Philadelphia, PA, specializing in hematologic oncology with a focus on allogeneic stem cell transplant and cellular immunotherapies. He completed his internal medicine residency at the University of Chicago and a fellowship in hematology and medical oncology at Temple University Hospital-Fox Chase Cancer Center and a transplant fellowship/immunology post-doc at Stanford University . Dr. Hossain has held academic roles as an Assistant Professor at the University of Pennsylvania and Loyola University Chicago. His research is published in various high-impact peer-reviewed journals, with topics including tumor lysis syndrome, hematopoietic cell transplantation, and CAR-T therapy, among others.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
University of ChicagoResidency, Internal Medicine, 2010 - 2013
Case Western Reserve University School of MedicineClass of 2010
Certifications & Licensure
PA State Medical License 2013 - 2026
CA State Medical License 2016 - 2025
IL State Medical License 2018 - 2023
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.Nasheed M Hossain, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Muhammad Bilal Abid
British Journal of Haematology. 2025-09-01 - Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis.Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr, Min Chen, Michael J Martens
Blood Advances. 2025-07-30 - 1 citationsTumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey
European Journal of Haematology. 2025-04-01
Abstracts/Posters
- Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-...Nasheed Hossain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)Nasheed Hossain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
‘Exciting’ Research Spotlights CAR-t’s Evolving Role in Blood Cancer TreatmentFebruary 22nd, 2023- Graft Versus Host Disease ResearchJune 17th, 2023
- Research into Graft Versus Host Disease (GVHD)June 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
